Benzinga.com: Spanish Healthcare Firm Grifols' Reputational Damage and Debt Woes: European Central Bank Probes Lenders
The European Central Bank (ECB) has initiated inquiries into several lenders, urging them to disclose their exposure to Grifols SA (NASDAQ:GRFS) and its affiliated entities following accusations of ...
Spanish Healthcare Firm Grifols' Reputational Damage and Debt Woes: European Central Bank Probes Lenders
The European Central Bank has contacted a number of lenders to Grifols (NASDAQ:GRFS) and its related entities in recent days to get information on their exposure to the troubled drugmaker, Reuters ...
SDxCentral: Orange Business completes first phases of data center infrastructure for Grifols Egypt
Yahoo Finance: Grifols (GRFS) Unveils AI-Driven Data for Early Parkinson’s Disease Detection
Benzinga.com: Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols
The investment firm has approached banks to secure funding to refinance Grifols' existing debt, which includes loans and high-yield bonds. In March, a new report by Gotham City Research questioned the ...
Brookfield Negotiates Over $10B In Debt Financing For Acquisition Of Spanish Pharma Giant Grifols
Grifols is a global, Spanish-based biotech company that is a favorite for many European investors, despite the fact that the company does not pay a dividend. It's one of the more well-known Spanish ...
Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ...
Orange Business has completed the first phase of data center infrastructure in Egypt's New Administrative Capital for Grifols Egypt for Plasma Derivatives (GEPD). In addition to the data center, ...